David N. Cook
Technik-/Wissenschafts-/F&E-Leiter bei FORMA THERAPEUTICS HOLDINGS, INC.
Aktive Positionen von David N. Cook
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
FORMA THERAPEUTICS HOLDINGS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2020 | - |
Global HIV Vaccine Enterprise
Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Global HIV Vaccine Enterprise engages in the development of preventive HIV vaccines. The company was founded in June 2003 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | 01.06.2011 | - |
Treasurer | 01.06.2011 | - | |
X-Biotix Therapeutics, Inc.
X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology X-Biotix Therapeutics, Inc. is a biotechnology company focused on the discovery and development, which focuses on the novel small molecule antibiotics that target resistant gram-negative bacteria. The company was founded by Ramani Varanasi in 2016 and is headquartered in Waltham, MA. | Direktor/Vorstandsmitglied | - | - |
Novome Biotechnologies, Inc.
Novome Biotechnologies, Inc. BiotechnologyHealth Technology Novome Biotechnologies, Inc. operates as a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The company was founded by William DeLoache, Weston Whitaker, Liz Shepherd and Zachary Russ in 2016 and is headquartered in South San Francisco, CA. | Direktor/Vorstandsmitglied | 26.05.2021 | - |
Karriereverlauf von David N. Cook
Ehemalige bekannte Positionen von David N. Cook
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SERES THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2012 | 01.03.2019 |
Corporate Officer/Principal | 07.02.2019 | 01.03.2019 | |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Geschäftsführer | 30.11.2010 | 01.10.2012 |
Bio Ventures for Global Health | Corporate Officer/Principal | 01.01.2009 | 01.02.2010 |
CERUS CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2001 | 01.11.2007 |
Eligix, Inc.
Eligix, Inc. Medical/Nursing ServicesHealth Services Eligix, Inc. develops and distributes medicines. It also offers cellular transplantation and immune therapies to enhance human immune response to cancers and infectious diseases. The company is located in Medford, MA | Technik-/Wissenschafts-/F&E-Leiter | 01.10.1999 | 01.08.2001 |
░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von David N. Cook
University of California, Berkeley | Doctorate Degree |
Harvard College | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 13 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Director/Board Member | 4 |
Chief Executive Officer | 2 |
Sektoral
Health Technology | 8 |
Consumer Services | 3 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
SERES THERAPEUTICS, INC. | Health Technology |
CERUS CORPORATION | Health Technology |
Private Unternehmen | 8 |
---|---|
Eligix, Inc.
Eligix, Inc. Medical/Nursing ServicesHealth Services Eligix, Inc. develops and distributes medicines. It also offers cellular transplantation and immune therapies to enhance human immune response to cancers and infectious diseases. The company is located in Medford, MA | Health Services |
Anza Therapeutics, Inc.
Anza Therapeutics, Inc. Medical SpecialtiesHealth Technology Anza Therapeutics, Inc. develops products in the fields of cancer and infectious diseases. It also develops immunotherapy for infectious diseases, therapeutic vaccines for treating cancers that over-express Mesothelin and for treating people infected with the hepatitis C virus (HCV). The company was founded in 2007 and is headquartered in Concord, CA. | Health Technology |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Health Technology |
Global HIV Vaccine Enterprise
Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Global HIV Vaccine Enterprise engages in the development of preventive HIV vaccines. The company was founded in June 2003 and is headquartered in New York, NY. | Commercial Services |
Bio Ventures for Global Health | |
X-Biotix Therapeutics, Inc.
X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology X-Biotix Therapeutics, Inc. is a biotechnology company focused on the discovery and development, which focuses on the novel small molecule antibiotics that target resistant gram-negative bacteria. The company was founded by Ramani Varanasi in 2016 and is headquartered in Waltham, MA. | Health Technology |
Forma Therapeutics Holdings, Inc.
Forma Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. engages in the research, development and commercialization of novel therapeutics for the treatment of hematologic diseases and cancers. Its product pipeline consists of FT-4202 for the treatment of sickle cell disease and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company was founded by Michael A. Foley in December 2011 and is headquartered in Watertown, MA. | Health Technology |
Novome Biotechnologies, Inc.
Novome Biotechnologies, Inc. BiotechnologyHealth Technology Novome Biotechnologies, Inc. operates as a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The company was founded by William DeLoache, Weston Whitaker, Liz Shepherd and Zachary Russ in 2016 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- David N. Cook
- Erfahrung